Section Arrow
SLNO.NASDAQ
- Soleno Therapeutics
Quotes are at least 15-min delayed:2025/04/12 04:14 EDT
Last
 67.23
+4.36 (+6.93%)
Day High 
67.37 
Prev. Close
62.87 
1-M High
74 
Volume 
985.36K 
Bid
65
Ask
68
Day Low
62.11 
Open
62.71 
1-M Low
43 
Market Cap 
2.88B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 67.98 
20-SMA 59.59 
50-SMA 52.4 
52-W High 74 
52-W Low 36.61 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.38/1.19
Enterprise Value
2.94B
Balance Sheet
Book Value Per Share
5.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals5.76+1.25+27.72%-- 
THTXTheratechnologies1.94+0.61+45.86%-- 
CDTConduit Pharmaceuticals Inc0.9101-0.1599-14.94%-- 
PRTGPortage Biotech Inc8.59+3.49+68.43%0.17PE
HEPAHepion Pharmaceuticals0.422-0.0091-2.11%-- 
Quotes are at least 15-min delayed:2025/04/12 04:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.